RoosterBio
PrivateLast Round
VC Round
Jul 25, 2024
Total Funding Raised
$23.85M
Company Overview
RoosterBio operates in Healthcare & Life Sciences and is based in Frederick, Maryland. Its latest recorded funding round was a VC Round in July 2024.
RoosterBio is a biotechnology company that provides human mesenchymal stem/stromal cells (hMSCs), bioprocess media, and manufacturing technologies for the cell therapy industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Pharma Supply Chain
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RoosterBio Comparables
Compare RoosterBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellcolabs | 79% | |
| Celprogen | 77% | |
| OrganaBio | 77% |
For institutional investors. Book with your work email.
RoosterBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 25, 2024 | ||||
| VC Round | Mar 22, 2024 | ||||
| Grant | May 9, 2023 | ||||
| Grant | May 16, 2022 | ||||
| Series B | Sep 10, 2019 | ||||
Grant | Jun 13, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RoosterBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dynamk Capital | Series B |
| Vanedge Capital | Series B |
| Bioeconomy Capital | Series B |
| Maryland Stem Cell Research Fund | Grant |
| BroadOak Capital Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 4, 2025
Monthly visitors increased 42% MoM.
- Jun 1, 2025
Monthly visitors increased 53% MoM, from 4.5K to 6.9K.
For institutional investors. Book with your work email.
RoosterBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RoosterBio's valuation, stock price, and market status.
Is RoosterBio a public or private company?
RoosterBio is a private company.
What is the current stock price of RoosterBio?
RoosterBio is a private company, so its shares have no public market price. Caplight tracks RoosterBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RoosterBio worth (valuation)?
Valuation information for RoosterBio is not publicly available.
Can I buy RoosterBio stock?
RoosterBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RoosterBio's last funding round?
RoosterBio's most recent funding round was VC Round on July 25, 2024.
Who are the main investors in RoosterBio?
Key investors in RoosterBio include Dynamk Capital, BroadOak Capital Partners.
Will RoosterBio IPO soon?
No public IPO plans have been announced for RoosterBio.
How can I track RoosterBio secondary market activity?
Caplight tracks bids, offers, and trades in RoosterBio's shares on secondary markets.